Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens [2]

Journal of Medicinal Chemistry

Volumn 43, Issue 6, 2000, Pages 1045-1049

  Or, Yat Sun ^a   Clark, Richard F ^a   Wang, Sanyi ^a   Chu, Daniel T W ^a   Nilius, Angela M ^a   Flamm, Robert K ^a   Mitten, Michael ^a   Ewing, Patty ^a   Alder, Jeff ^a   Ma, Zhenkun ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HMR 3004; KETOLIDE; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATION; DRUG DESIGN; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; LETTER; MULTIDRUG RESISTANCE; PATHOGENESIS; PROTEIN DEGRADATION; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; HAEMOPHILUS INFLUENZAE; LUNG; LUNG DISEASES; MACROLIDES; MICE; MODELS, MOLECULAR; RATS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0000184017     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990618n     Document Type: Letter

References (40)

1. (a) Bax, R. P.; Anderson, R.; Crew, J.; Fletcher, P.; Johnson, T.; Kaplan, E.; Knaus, B.; Kristinsson, K.; Malek, M.; Strandberg, L. Antibiotic Resistance-What Can We Do? Nature Med. 1998, 4, 545-546.
2. (b) Baquero, F. Gram-Positive Resistance: Challenge for the Development of New Antibiotics. J. Antimicrob. Chemother. 1997, 39, Suppl. A, 1-6.
3. Schentag, J. J.; Hyatt, J. M.; Carr, J. R.; Paladino, J. A.; Birmingham, M. C.; Zimmer, G. S.; Gumbo, T. J. Genesis of Methicillin-Resistant Staphylococcus aureus (MRSA), How Treatment of MRSA Infections Has Selected for Vancomycin-Resistant Enterococcus faecium, and the Importance of Antibiotic Management and Infection Control. Clin. Infect. Dis. 1998, 26, 1204-1214.
4. (a) Jacobs, M. R.; Bajaksouzian, S.; Zilles, A.; Lin, G.; Pankuch, G. A.; Appelbaum, P. C. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance Study. Antimicrob. Agents Chemother. 1999, 43, 1901-1908.
5. (b) Thornsberry, C.; Ogilvie, P. T.; Holley, H. P.; Sahm, D. F. Survey of Susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study. Antimicrob. Agents Chemother. 1999, 43, 2612-2623.
6. (c) Barry, A. L. Antimicrobial Resistance Among Clinical Isolates of Streptocuccus pneumoniae in North America. Am. J. Med. 1999, 107, 28S-33S.
7. (d) Tomasz, A. New Faces of an Old Pathogen: Emergence and Spread of Multidrug-Resistant Streptoccus pneumoniae. Am. J. Med. 1999, 707, 55S-59S.
8. Doern, G. V.; Pfaller, M. A.; Kugler, K.; Freeman, J.; Jones, R. N. Prevalence of Antimicrobial Resistance Among Respiratory Tract Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program. Clin. Infect. Dis. 1998, 27, 764-770.
9. Doern, G. V.; Jones, R. N.; Pfaller, M. A.; Kugler, K. THE SENTRY PARTICIPANTS GROUP. Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 1999, 43, 385-389.
10. Omura, S.; Tsuzuki, K.; Sunazuka, T.; Marui, S.; Toyoda, H.; Inatomi, N.; Itoh, Z. Macrolide with Gastrointestinal Motor Stimulating Activity. J. Med. Chem. 1987, 30, 1943-1948.
11. For reviews, see: (a) Chu, D. T. W. Recent Developments in 14- and 15-Membered Macrolides. Exp. Opin. Invest. Drugs 1995, 4, 65-94.
12. (b) Bryskier, A.; Agouridas, C.; Gase, J.-C. Classification of Macrolide Antibiotics. In Macrolide; Bryskier, A. J., Butzler, J.-P., Neu, H. C., Tulkens, P. M., Eds.; Arnette Blackwell: Paris, 1993; pp 5-66.
13. (a) Weisblum, B. Macrolide Resistance. Drug Resistance Updates 1998, 1, 29-41.
14. (b) Amsden, G. W. Pneumococcal Macrolide Resistance-Myth or Reality. J. Antimicrob. Chemother. 1999, 44, 1-6.
15. (c) Bryskier, A. Novelties in the Field of Macrolides. Exp. Opin. Invest. Drugs 1997, 6, 1697-1709.
16. (d) Bryskier, A. New Research in Macrolides and Ketolides since 1997. Exp. Opin. Invest. Drugs 1999, 8, 1171-1194.
17. (a) Agouridas, C.; Benedetti, Y.; Denis, A.; Le Martret, O.; Chantot, J. F. Ketolides: A New Distinct Class of Macrolide Antibacterials. Synthesis and Structural Characterization of RU 004. 35th Interscience Conference on Antimicrobial Agents and Chemiotherapy, San Francisco, CA, 1995; Abstr. No. F157.
18. (b) Agouridas, C.; Denis, A.; Auger, J.; Benedetti, Y.; Bonnefoy, A.; Bretin, F.; Chantot, J.; Dussarat, A.; Fromentin, C.; D'Ambrieres, S. G.; Lachaud, S.; Laurin, P.; Le Martret, O.; Loyau, V.; Tessot, N. Synthesis and Antibacterial Activity of Ketolides (6-O-Methyl-3-Oxoerythromycin Derivatives): A New Class of Antibacterials Highly Potent Against Macrolide Resistant and Susceptible Respiratory Pathogens. J. Med. Chem. 1998, 41, 4080-4100.
19. (a) Domagala, J. M.; Sanchez, J. P. New Approaches and Agents to Overcome Bacterial Resistance. Annu. Rep. Med. Chem. 1997, 32, 111-120.
20. (b) Chopra, I.; Hodgson, J.; Metcalf, B.; Poste, G. The Search for Antimicrobial Agents Effective against Bacteria Resistant to Multiple Antibiotics. Antimicrob. Agents Chemother. 1997, 41, 479-503.
21. (c) Coleman, K.; Athalye, M.; Clancey, A.; Davison, M.; Payne, D. J.; Perry, C. R.; Chopra, I. Bacterial Resistance Mechanism as Therapeutic Targets. J. Antimicrob. Chemother. 1994, 33, 1091-1116.
22. See ref 8a and: (a) Nakajima, Y. Mechanism of Bacterial Resistance to Macrolide Antibiotics. J. Infect. Chemother. 1999, 5, 61-74.
23. (b) Hansen, L. H.; Mauvais, P.; Douthwaite, S. The Macrolide-Ketolide Antibiotic Binding Site Is Formed by Structures in Domain II and V of 23S Ribosomal RNA. Mol. Microbiol. 1999, 31, 623-631.
24. (c) Xiong, L.; Shah, S.; Mauvais, P.; Mankin, A. S. A Ketolide Resistance Mutation in Domain II of 23S rRNA Reveals the Proximity of Hairpin 35 to the Peptidyl Transferase Center. Mol. Microbiol. 1999, 31, 633-639.
25. Fernandes, P. B.; Baker, W. R.; Freiberg, L. A.; Hardy, D. J.; McDonald E. J. New Macrolides Active against Streptococcus pyogenes with Inducible or Constitutive Type of Macrolide-Lincosamide-Streptogramin B Resistance. Antimicrob. Agents Chemother. 1989, 35, 78-81.
26. Denis, A.; Agouridas, C.; Auger, J.-M.; Benedetti, Y.; Bonnefoy, A.; Bretin, F.; Chantot, J.-F.; Dussarat, A.; Fromentin, C.; D'Ambrieres, S. G.; Lachaud, S.; Laurin, P.; Martret, O. L.; Loyau, V.; Tessot, N.; Pejac, J.-M.; Perron, S. Synthesis and Antibacterial Activity of HMR 3647. A New Ketolide Highly Potent against Erythromycin-Resistant and Susceptible Pathogens. Bioorg. Med. Chem. Lett. 1999, 9, 3075-3080.
27. Asaka, T.; Kashimura, M.; Misawa, Y.; Ono, T.; Suzuki, K.; Yoshida, T.; Akashi, T.; Yokoo, C.; Nagate, T.; Morimoto, S. A New Macrolide Antibiotics, TE-802: Synthesis and Biological Properties. 35th Interscience Conference on Antimicrobial Agents and Chemiotherapy, San Francisco, CA, 1995; Abstr. No. F176.
28. See ref 9b for crystal structure of RU-004. For solution conformations of macrolides, see: (a) Awan, A.; Brennan, R. J.; Regan, A. C.; Barber, J. Conformational Analysis of the Erythromycin Analogues Azithromycin and Clarithromycin in Aqueous Solution and Bound to Bacterial Ribosomes. J. Chem. Soc., Chem. Commun. 1995, 1653-1654.
29. (b) Bertho, G.; Ladam, P.; Gharbi-Benarous, J.; Delaforge, M.; Girault, J.-P. Solution Conformation of Methylated Macrolide Antibiotics Roxithromycin and Erythromycin Using NMR and Molecular Modelling. Ribosome-Bound Conformation Determined by TRNOE and Formation of Cytochrome P450-Metabolite Complex. Int. J. Biol. Macromol. 1998, 22, 103-127.
30. (c) Bertho, G.; Gharbi-Benarous, J.; Delaforge, M.; Girault, J.-P. Transferred Nuclear Overhauser Effect Study of Macrolide-Ribosome Interactions: Correlation between Antibiotic Activities and Bound Conformations. Bioorg. Med. Chem. 1998, 6, 209-221.
31. (d) Bertho, G.; Gharbi-Benarous, J.; Delaforge, M.; Lang, C.; Parent, A.; Girault, J.-P. Conformational Analysis of Ketolide, Conformations of RU 004 in Solution and Bound to Bacterial Ribosomes. J. Med. Chem. 1998, 41, 3373-3386.
32. For a summary of earlier work, see: Lartey, P. A.; Perun, T. J. Synthetic Modifications of the Erythromycin A Macrolactone: Effects on Biological Activity. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Scientific Publishers: Amsterdam, 1993; Vol. 13, pp 155-185.
33. Morimoto, S.; Matsunaga, T.; Adachi, T.; Kashimura, M.; Asaka, T.; Sola, K.; Watanabe, Y.; Sekiuchi, K. Preparation of Erythromycin A Derivatives. European Patent EP 272110 A2, 1988.
34. t (2.0 equiv) in DMSO/THF was added slowly over 4 h to an ice-cold solution of 1 and allyl bromide (2.0 equiv) in DMSO/THF with vigorous agitation. Crude product obtained after normal aqueous workup was carried to the next step without purification.
35. Or, Y. S.; Ma, Z.; Clark, R. F.; Chu, D. T.; Plattner, J. J.; Griesgraber, G. Preparation of 6-O-Substituted Erythromycin Ketolides as Antibacterial Agents. U.S. Patent US 5866549, 1998.
36. Corey, E. J.; Kim, C. U. New and Highly Effective Method for the Oxidation of Primary and Secondary Alcohols to Carbonyl Compounds. J. Am. Chem. Soc. 1972, 94, 7586-7587
37. Cabri, W.; Candiani, I. Recent Developments and New Perspectives in the Heck Reaction. Acc. Chem. Res. 1995, 28, 2-7.
38. 3CN was degassed and sealed in a pressure tube. Reaction mixture was heated at 90°C for 24 h, followed by a normal workup.
39. (a) Elliott, R. L.; Pireh, D.; Griesgraber, G.; Nilius, A. M.; Ewing, P. J.; Bui, M. H.; Raney, P. M.; Flamm, R. K.; Kim, K.; Henry, R. F.; Chu, D. T. W.; Plattner, J. J.; Or, Y. S. Anhydrolide Macrolides. 1. Synthesis and Antibacterial Activity of 2,3-Anhydro-6-O-Methyl 11,12-Carbamate Erythromycin A Analogues. J. Med. Chem. 1998, 41, 1651-1659.
40. (b) Griesgraber, G.; Kramer, M. J.; Elliott, R. L.; Nilius, A. M.; Ewing, P. J.; Raney, P. M.; Bui, M.-H.; Flamm, R. K.; Chu, D. T. W.; Plattner, J. J.; Or, Y. S. Anhydrolide Macrolides. 2. Synthesis and Antibacterial Activity of 2,3-Anhydro-6-O-Methyl 11,12-Carbazate Erythromycin A Analogues. J. Med. Chem. 1998, 41, 1660-1670.